Professional Documents
Culture Documents
Focal
Diffuse
TERMS
Global
segmental
only a part of the glomerulus is affected (most focal lesions are also segmental)
proliferative
^cell numbers due to hyperplasia of one or more of the resident glomerular cells
membrane
alterations
crescent formation
GLOMERULONEPHRITIS
Glomerular dx
Tubulo-interstitial dx rarely
causes significant proteinuria
Physical exercise
Orthostatic proteinuria
Fever
Heart failure
Pregnancy
Presentation
Diagnosis
Treatm
ent
Prognos
is
IgA
Nephropathy
altered
regulation of IgA
^IgA possibly
due to infection,
which forms
immune
complexes and
deposits in
mesangial cells.
HenochSchonlein
Purpura (HSP)
Systemic IgA
nephropathy,
causing a small
vessel
vasculitis.
Systemic
lupus
erythematous
(SLE)
Common cause of
GN in adults
Young man (20-30
yo), Asians and
Caucasians with
episodic
macroscopic
haematuria,
recovery is often
rapid between
attacks
purpuric rash on
extensor surfaces
Arthralgias
Purpura
Abdominal pain,
GI bleeding
Hematuria
Mesangial
proliferation,
immunofluores
cence (IF)
shows deposits
of IgA and C3
+ IF for IgA
and C3 in skin
or renal biopsy.
Antiglomerular
basement
membrane
(GBM)
A.k.a.
Goodpastures
disease caused
by autoantibodies to
type IV collagen
an essential
component of
the GBM
Poststreptococcal
Strep. Ag is
deposited on
the glomerulus
causing a host
rxn and immune
complex form.
Pulmonary
haemorrhage
Haematuria/nephi
ritc syndrome
AKI may occur
within days of
onset of
symptoms
Malaise, fatigue,
anorexia, weight
loss, arthralgias,
myalgias
A/b develop
against 3
chain type IV
collagen in
GBM. Linear
deposition of
IgG along GBM
A/b detected
by ELISA
ANCA
capillary loop
staining with
IgG and C3
and extensive
crescent
formation
Urinalysis
Inflammation
rxn affecting
mesangial and
endothelial
cells
IF: IgG and C3
deposits
^ASOT ^C3
Control
BP with
ACEi,
immuno
suppres
sion
may
slow
decline
of renal
function
.
~15% ->
ESRF. If
same as
both
IgA
nephritic
nephrop
and
athy
nephroti
c 50% ->
ESRF
~1/3 SLE have renal
disease with vascular,
glomerular and
tubulointerstitial
damage.
Relapse
are rare.
Prognosi
s is poor
if
dialysisdepende
nt
presenta
tion.
Complica
tion
Severe
HPT,
renal
failure,
primary
disease
(SLE)
Plasma
exchan
ge,
steroids
,
Cycloph
ospham
ide
~20% ->
ESRF.
POOR
prognosi
s: Male,
^BP,
proteinur
ia or
renal
failure at
presenta
tion.
Rapidly
progressive
Most aggressive
GN. Could cause
ESRF over days.
AKI +- systemic
features (fever,
myalgia, weight
loss,
haemoptysis)
Pulmonary
haemorrhage is
the commonest
cause of death
ANCA +ve
patients
-
Aggressive
immunosupresion with
high-dose IV steroids
and cyclophophamide
+- plasma exchange
5 year survival 80%
NEPHROTIC SYNDROME
1. Definition: the renal excretion of more than 3.5g of protein during a 24 hour period
2. Assessed by the collection of a cumulative 24h urine specimen.
3. As a result of abnormalities of the basement membrane, large amounts of plasma
proteins are filtered into the glomerular ultrafiltrate
4. Not associated with significant glomerular inflammation and red blood cell casts or other
signs of glomerular inflammation are present
5. The loss of nephrotic quantities of proteins for prolonged periods can result in
hypoproteinamia
6. Peripheral oedema because of loss of plasma oncotic pressure
Criteria
OEDEMA
Nephrotic syndrome is NOT a diagnosis. Therefore, the underlying cause should always be
sought.
Presentation
i.
ii.
iii.
Facial oedema
Peripheral oedema
Pleural effusion
iv.
v.
Ascites
Genital and sacral oedema
vi.
MESANGIOCAPILLARY GN
1. Immune complex (IC)
Driven by circulating immune complexes, which deposit in the kidney and activate
complement via the classical pathway. An underlying cause can be found in most
cases, eg Hep C, SLE and monoclonal gammopathies.
2. Complement mediated
Less common and involves persistent activation of the alternative complement
pathway
3. BIOPSY: mesangial and endocapillary proliferation, a thickened capillary basement
membrane, double contouring (tramline) of the capillary walls. IF can show Ig
staining, complement staining or light chains depending on cause. EM shows electron
dense deposits.
Complication
A. DVT
a. Hypercoagulable state due to urinary losses of anti-thrombin and thrombocytosis
b. Exacerbated by steroid therapy
c. Increased synthesis of clotting factors
d. Increased blood viscosity from the raised haematocrit
e. This is usually arterial and may affect the brain, limbs, and splanchnic circulation.
B. Pulmonary infection, Sepsis
a. Serum: IgG, complement, T cell function
b. Steroid: immunosuppressant toxicity
C. Accelerated atherosclerosis. Lipid abnormalities
D. Hypovolaemia
E. Acute renal failure (rare)
Investigation
DIAGNOSTIC
1.
2.
3.
4.
5.
FURTHER INVESTIGATION
1. Full blood count: HCT, WBC
2. Renal profile: normal in MCD
U+Es; Creatinine
3. Serum albumin: <25g/L
4. Urinalysis and quantification for
urinary protein excretion
abundant hyaline cast
Haematuria (other than MCD)
Na+ <10mmol/L in
hypovolaemia
Glucose
5. LFTs; ASOT
6. Urine culture
7. Varicella status should be known in
all children commencing steroids.
8. Other investigations
complement levels: suggest
other thn MCD
Antistreptolysin O titre and
throat swab
Hepatitis B antigen
9. Biopsy light microscopy/ EM/ IF
6. Management
Initial treatment
- Na restriction and THIAZIDE diuretics
- Unresponsive patients require
FUROSEMIDE 40-120mg daily +
amiloride
Normal protein intake
Albumin infusion
- only produce a transient effect
- Indication: diuretic-resistant, oliguria
and uraemia in the absence of severe
glomerular damage e.g. in minimal
change nephropathy.
Hypercoagulable states
- Predispose to venous thrombosis
NEPHRITIC SYNDROME
Variable amounts of proteinuria with the presence of RED BLOOD CELL CASTS (linear
aggregates of RBC formed in tubules as a consequence of glomerular haemorrhage)
And other inflammatory features (WBC and tubular cell casts) on urinalysis
Clinical features
i.
ii.
iii.
iv.
v.
Hypertension
Haematuria (usually micro, but can be macro)
Oliguria/acute renal failure
+/- odema
May be associated proteinurea
Crescenteric Glomerulonephritis
IgA Nephropathy
1.
2.
3.
4.
RECURRENT UTI
1. Same symptoms
2. No fixed definition of recurrent
a. 2 infections in 6 months
b. 3 infections in 12 months
3. After a single UTI there is a 30% risk of recurrence with 6 months
4. 60% will be the same organism (E coli)
5. After a first UTI 30-40% of patients will go onto have recurrent infections
Complicated or uncomplicated
a.
b.
c.
d.
Investigations
1.
2.
3.
4.
5.
Treatment
Low dose, once daily prophylactic antibiotics is an effective treatment for recurrent UTI.
Treatment significantly reduces the frequency of infection.
There is a risk on increasing antibiotic resistance and therefore treatment should be
reserved for patients with frequent, disabling infections.
Treatment should be for a limited period of time, usually 1-2 years, after which treatment
should be stopped and the patient re-assessed.
Single dose post-coital antibiotics can also be effective, particularly if infections follow
intercourse.
6.